| | 131410-48-5 Basic information More.. |
| Product Name: | Gadodiamide | | Synonyms: | Gd-DTPA-BMA;S-041;GADODIAMIDE (500 MG);gadolinium 2-[bis[2-(carboxylatomethyl-(methylcarbamoylmethyl)amino)ethyl]amino]acetate;GADODIAMIDE;Omniscan;[5，8-Bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2，5，8，11-tetraaza-tridecan-13-oato(3-)]gadolinium;2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxoethyl]amino]ethyl]amino]acetate | | CAS: | 131410-48-5 | | MF: | C16H26GdN5O8 | | MW: | 573.66 | | EINECS: | | | Mol File: | 131410-48-5.mol |  |
Use
Gadodiamide is a clear,colorless to slightly yellow, gadolinium-based contrastagent indicated to visualize lesions with abnormal vascularityin the CNS and body. It is a nonionic gadoliniumcomplex administered by intravenous injection with an osmolalityof 2.8 times that of plasma. Gadodiamide decreasesboth the T1 and T2 relaxation times in tissueswhere it is distributed. In clinical MRI, the effect is primarily on the T1 relaxation time resulting in an increase inT1-weighted sequence signal intensity.
- Gadodiamide
-
- US $1.00 / kg
- 2019-07-06
- CAS:131410-48-5
- Min. Order: 1kg
- Purity: 95%-99%
- Supply Ability: 100kg
|
|
131410-48-5
Recommend Suppliers |
|